Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified T cells

Overview of attention for article published in Science Translational Medicine, September 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 53 news outlets
blogs: 5 blogs
twitter: 50 X users

patent: 19 patents
facebook: 3 Facebook pages
googleplus: 1 Google+ user

Citations

dimensions_citation: 841 Dimensions

Readers on

mendeley: 686 Mendeley

Summary News Blogs X Patents Facebook Google+ Dimensions citations

So far, Altmetric has seen 1 Google+ post.

08 Sep 2016

Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified…

This page shows the most recent Google+ posts that mention this research output.

Click here to find out how to access more activity.